Skip to main content

Advertisement

Log in

Rescue of Cytokine Storm Due to HLH by Hemoadsorption in a CTLA4-Deficient Patient

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009;10(3):387–92.

    Article  PubMed  Google Scholar 

  2. Bode SF, Lehmberg K, Maul-Pavicic A, et al. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther. 2012;14(3):213.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Schubert D, Bode C, Kenefeck R, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20(12):1410–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lo B, Zhang K, Lu W, et al. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349(6246):436–40.

    Article  CAS  PubMed  Google Scholar 

  5. Dalal RS, LeGolvan MP, Stachurski DR, Goldberg LR. Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in a rheumatic patient receiving abatacept therapy. Rhode Island Medical Journal. 2014;97(8):28–31.

    PubMed  Google Scholar 

  6. Henter J-I, Samuelsson-Horne A, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100(7):2367–73.

    Article  CAS  PubMed  Google Scholar 

  7. Frimmel S, Schipper J, Henschel J, et al. First description of single-pass albumin dialysis combined with cytokine adsorption in liver failure and hemophagocytic syndrome resulting from generalized herpes simplex virus 1 infection. Available at: http://cytosorb-therapy.com/wp-content/uploads/2016/06/Caseoftheweek_24_E_one_page.pdf

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Klaus Warnatz.

Ethics declarations

Funding

This study was supported by the German Federal Ministry of Education and Research (BMBF 01EO1303) (to KW, BG). The authors are responsible for the contents of this publication.

Conflict of Interest

KW has received a research grant from BMS, honoraria for consultant services from LFB, and for speaking engagements from Octapharma and Baxalta. FR has received an educational grant and speaker honorarium from Pfizer. Our ICU team received technical support during the CytoSorbTM application by the supplier. CG, PLR, BG, and DD declare that they have no conflict of interest.

Additional information

Daniel Duerschmied and Klaus Warnatz contributed equally to this report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Greil, C., Roether, F., La Rosée, P. et al. Rescue of Cytokine Storm Due to HLH by Hemoadsorption in a CTLA4-Deficient Patient. J Clin Immunol 37, 273–276 (2017). https://doi.org/10.1007/s10875-017-0377-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-017-0377-7

Keywords

Navigation